Coronary artery disease in women. Risk factors, evaluation, treatment, and prevention

Area of Science:

• Cardiology
• Women's Health
• Medical Research

Background:

• Cardiovascular disease (CVD) is the primary cause of mortality in women.
• Historically, women have been underrepresented in major clinical trials for CVD, leading to knowledge gaps.
• Evidence suggests potential gender bias in the aggressive intervention and treatment of CVD in women.

Purpose of the Study:

• To review the current understanding of cardiovascular disease in women.
• To highlight risk factors, identification methods, and treatment strategies specific to women.
• To explore the potential benefits of postmenopausal estrogen therapy for cardiovascular health in women.

Main Methods:

• Literature review of existing studies on cardiovascular disease in women.
• Analysis of risk factors, diagnostic approaches, and therapeutic interventions.
• Examination of research on postmenopausal estrogen therapy and its cardiovascular implications.

Main Results:

• Significant underrepresentation of women in pivotal cardiovascular trials.
• Potential existence of gender bias affecting treatment intensity for women.
• Identification of specific risk factors and diagnostic challenges in female patients.
• Emerging data on the role of postmenopausal estrogen in cardiovascular disease management.

Conclusions:

• There is a critical need to address the historical neglect of cardiovascular disease research in women.
• Further research and equitable clinical practices are essential to improve cardiovascular outcomes for women.
• Postmenopausal estrogen therapy warrants consideration as a potential therapeutic option, requiring further investigation.